PAION
PAION AG, together with its subsidiaries, operates as a biopharmaceutical company that engages in developing and commercializing drug candidates for diseases or interventions with a substantial unmet medical need. The company’s lead compound is remimazolam, an intravenous, ultra-short-acting, and controllable benzodiazepine sedative/anesthetic drug candidate for which PAION has completed the clinical development for use in procedural sedation in the U.S. Outside. The product can be used for general anesthesia in Europe and procedural sedation in the United States. It was founded in 2000 and is based in Aachen, Nordrhein-Westfalen, Germany.
PAION
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2000-01-01
Address:
Aachen, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.paion.com
Total Employee:
11+
Status:
Active
Contact:
+49 241 4453-0
Email Addresses:
[email protected]
Total Funding:
41.11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Nginx Microsoft Exchange Online Office 365 Mail ReCAPTCHA JsDelivr
Similar Organizations
CeNeS
CeNeS is a biopharmaceutical company that develops and commercializes drugs for pain control, sedation and other CNS disorders.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2008-06-23 | CeNeS | CeNeS acquired by Paion | N/A |
Investors List
Reference Capital SA
Reference Capital SA investment in Series D - Paion
Reference Capital SA
Reference Capital SA investment in Series C - Paion
Reference Capital SA
Reference Capital SA investment in Series A - Paion
Official Site Inspections
http://www.paion.com Semrush global rank: 8.81 M Semrush visits lastest month: 251
- Host name: ms11730.ispgateway.de
- IP address: 134.119.0.208
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
More informations about "Paion"
Paion
PAION AG is a publicly listed specialty pharmaceutical company developing and aiming to commercialize innovative drugs to be used in out-patient and hospital-based sedation, anesthesia and critical care services. PAION's lead …See details»
Paion (company) - Paion (Unternehmen) - Second Wiki
Paion also signed an agreement with Forest Laboratories in 2004 to develop and commercialize Desmoteplase in the United States and Canada. In 2005 the company entered into an …See details»
PAION AG - Drug pipelines, Patents, Clinical trials - Synapse
Explore PAION AG with its drug pipeline, therapeutic area, technology platform, 27 clinical trials, 5 news, and 54 literature, Disease Domain:Infectious Diseases, Hemic and Lymphatic Diseases, …See details»
Paion Company Profile 2024: Stock Performance & Earnings
Paion AG is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural …See details»
Paion - Org Chart, Teams, Culture & Jobs - The Org
View Paion's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Paion - businessabc.net
Sep 30, 2024 PAION AG is a specialty pharmaceutical company based in Germany that develops and commercializes innovative drugs for the treatment and diagnosis of medical …See details»
Paion - Crunchbase Company Profile & Funding
Bio portfolio — paion ag raises eur 5.2 million in private placement Funding Round • Aug 1, 2001 Paion raised $3,200,000 / Series B from LG Venture Investment and 2 other investorsSee details»
Paion - Funding, Financials, Valuation & Investors - Crunchbase
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs. Search Crunchbase. Start Free Trial . ...See details»
Paion Company Profile - Office Locations, Competitors, Revenue
Oct 29, 2024 Paion has 3 employees across 4 locations and €33.25 m in annual revenue in FY 2022. See insights on Paion including office locations, competitors, revenue, financials, …See details»
PAION AG | Devex
PAION AG is a publicly listed specialty pharmaceutical company developing and aiming to commercialize innovative drugs for out-patient and hospital-based sedation, anesthesia and …See details»
Paion: Shareholders Board Members Managers and Company …
Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In …See details»
PAION AG Information - RocketReach
PAION AG is a publicly listed specialty pharmaceutical company with innovative drugs to be used in hospital-based sedation, anesthesia and critical care services. PAION’s lead compound is …See details»
Paion - Overview, News & Similar companies | ZoomInfo.com
Mar 29, 2022 Who is Paion. PAION AG is a publicly listed specialty pharmaceutical company focused on developing and commercializing innovative drugs for out-patient and hospi tal …See details»
PAION - Products, Competitors, Financials, Employees, …
PAION overview PAION operates as a specialty pharmaceutical company that develops and commercialization drugs used for outpatient and hospital-based sedation, anesthesia and …See details»
Paion CEO and Key Executive Team | Craft.co
Paion's Chairman of the Audit Committee is Chris Tanner. Other executives include Markus Leyck Dieken, Board Member; James Phillips, Chief Executive Officer of PAION AG, Managing …See details»
PA8 Stock Price Quote - Morningstar
Nov 7, 2024 Paion AG is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for …See details»
Paion - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 1, 2001: Series B - Paion . …See details»
What is PAION? Company Culture, Mission, Values | Glassdoor
PAION. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. Claim your Free …See details»
PAY.ON AG - Crunchbase Company Profile & Funding
PharmiWeb.com — PAION AG to issue approximately 4.8 million shares in capital increase with subscription rights News • Nov 30, 2022 PharmiWeb.com — PAION AG announces change in …See details»